LEADER 03410nam 2200565 a 450 001 9910454491403321 005 20200520144314.0 010 $a1-281-74403-4 010 $a9786611744038 010 $a92-4-068310-0 035 $a(CKB)1000000000690056 035 $a(EBL)349986 035 $a(OCoLC)476167593 035 $a(MiAaPQ)EBC349986 035 $a(Au-PeEL)EBL349986 035 $a(CaPaEBR)ebr10233795 035 $a(CaONFJC)MIL174403 035 $a(OCoLC)437213722 035 $a(EXLCZ)991000000000690056 100 $a20080903d2008 uy 0 101 0 $aeng 135 $aurcn||||||||| 200 00$aWHO Expert Committee on Specification for Pharmaceutical Preparations$b[electronic resource] $eforty-second report 210 $aGeneva, Switzerland $cWorld Health Organization$d2008 215 $a1 online resource (150 p.) 225 1 $aWHO technical report series,$x0512-3054 ;$v948 300 $aDescription based upon print version of record. 311 $a92-4-120948-8 320 $aIncludes bibliographical references. 327 $aPreliminaries; Contents; 1 Introduction; 2 General policy; 3 Quality control specifications and tests; 4 Quality control International Chemical Reference Substances and International Infrared Reference Spectra; 5 Quality control national laboratories; 6 Quality assurance good manufacturing practices; 7 Quality assurance new approaches and risk analysis; 8 Quality assurance distribution and trade of pharmaceuticals; 9 Quality assurance stability; 10 Prequalification of priority essential medicines and devices; 11 Prequalification of active pharmaceutical ingredients 327 $a12 Prequalification of quality control laboratories 13 Active pharmaceutical ingredient master file; 14 Regulatory guidance; 15 Nomenclature terminology and databases; 16 Miscellaneous; 17 Summary and recommendations; Acknowledgements; and International Infrared Reference Spectra; condoms for purchase by United Nations agencies; intrauterine devices for purchase by United Nations agencies; Guidelines on active pharmaceutical ingredient mas 330 $aThe Expert Committee on Specifications for Pharmaceutical Preparations works towards clear, independent and practical standards and guidelines for medicines' quality assurance. Standards are developed by the Committee through worldwide consultation and an international consensus building process. The forty-second meeting adopted 11 new monographs for inclusion in The International Pharmacopoeia (Ph.Int.) and seven related new International Chemical Reference Standards (ICRS). The specifications currently developed are internationally applicable test methodologies for antimalarial, antitubercul 410 0$aTechnical report series (World Health Organization) ;$v948. 606 $aDrugs$xStandards 606 $aPharmaceutical technology$xStandards 606 $aDrugs$xLaw and legislation 608 $aElectronic books. 615 0$aDrugs$xStandards. 615 0$aPharmaceutical technology$xStandards. 615 0$aDrugs$xLaw and legislation. 676 $a615.1 676 $a615/.1 712 02$aWorld Health Organization. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910454491403321 996 $aWHO Expert Committee on Specification for Pharmaceutical Preparations$91974787 997 $aUNINA LEADER 02655 am 2200421 n 450 001 9910515996603321 005 20220106 010 $a2-940600-36-8 024 7 $a10.4000/books.iheid.8612 035 $a(CKB)4100000012311065 035 $a(FrMaCLE)OB-iheid-8612 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/85478 035 $a(PPN)260398748 035 $a(EXLCZ)994100000012311065 100 $a20220107j|||||||| ||| 0 101 0 $aeng 135 $auu||||||m|||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe Haralds of Hydrogen $eThe Economic Sectors Driving the Hydrogen Economy in Europe /$fFloris Jacobus Adrianus de Klerk Wolters 210 $aGeneva $cGraduate Institute Publications$d2022 225 1 $aeCahiers de l?Institut 330 $aThis paper analyses membership data from 39 hydrogen associations to understand which economic sectors support the hydrogen transition in Europe, and why. It finds support from manufacturers of motor vehicles, chemicals, (electronic and electrical) machinery, electricity and gas companies, companies working in transport and storage (including ports), oil and gas companies, and many professional, scientific, and technical companies. Chemicals manufacturers and natural gas utilities stand out in their interest, as well as SMEs working in the value chain of hydrogen and fuel cell products. Registrations are clustered in the North Sea Region and the Iberian Peninsula, with many fewer registrations in Italy and Eastern Europe (including Russia). Motives for supporting the hydrogen transition include sales and market growth, rising CO2 emissions costs, regulatory and public pressure to decarbonise, avoiding stranded assets, diversification, investor concerns about the long-term profitability of carbon-intensive sectors, and sector-specific concerns. We extend our heartfelt thanks to the Vahabzadeh Foundation for financially supporting the publication of best works by young researchers of the Graduate Institute, giving a priority to those who have been awarded academic prizes for their master?s dissertations. 606 $aEconomics$2bicssc 610 $aGHG emissions 610 $atransport of hydrocarbons 610 $aoffshore gas and oil industry 610 $ahydrogen 610 $aenergy transition 610 $aEuropean Green Deal 615 7$aEconomics 700 $ade Klerk Wolters$b Floris Jacobus Adrianus$01292202 801 0$bFR-FrMaCLE 906 $aBOOK 912 $a9910515996603321 996 $aThe Haralds of Hydrogen$93022137 997 $aUNINA